STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency
NCT00263237
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
NIH
Sponsor class
Conditions
Common Variable Immunodeficiency
Interventions
DRUG:
STA-5326
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)